Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer

  Free Subscription


25.09.2017

1 Acta Oncol
1 Am J Obstet Gynecol
1 Anticancer Agents Med Chem
1 Biochem Cell Biol
2 Cancer
1 Cancer Cell Int
1 Cancer Prev Res (Phila)
1 Cancer Sci
1 Curr Opin Oncol
1 Eur J Cancer Care (Engl)
1 Eur J Med Res
1 Eur J Nucl Med Mol Imaging
1 Eur J Surg Oncol
1 Exp Ther Med
1 Fam Community Health
1 Front Public Health
6 Gynecol Oncol
3 Int J Cancer
2 Int J Gynaecol Obstet
1 Int J Nanomedicine
1 J Cancer Res Clin Oncol
1 J Health Commun
1 J Immigr Minor Health
1 J Oncol
1 J Pathol
1 J Robot Surg
1 J Surg Oncol
1 MMWR Morb Mortal Wkly Rep
1 Mutat Res
1 Oncoimmunology
3 Oncol Lett
1 Phys Med Biol
1 PLoS One
1 Updates Surg
1 World J Surg Oncol
1 Zhonghua Liu Xing Bing Xue Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Oncol

  1. BERGER T, Petersen JBB, Lindegaard JC, Fokdal LU, et al
    Impact of bowel gas and body outline variations on total accumulated dose with intensity-modulated proton therapy in locally advanced cervical cancer patients.
    Acta Oncol. 2017 Sep 21:1-7. doi: 10.1080/0284186X.2017.1376753.
    PubMed     Text format     Abstract available


    Am J Obstet Gynecol

  2. BEAN LM, Ward KK, Plaxe SC, McHale MT, et al
    Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery.
    Am J Obstet Gynecol. 2017;217:332.
    PubMed     Text format     Abstract available


    Anticancer Agents Med Chem

  3. SUNDARAM MK, Ansari MZ, Mutery AA, Ashraf M, et al
    Genistein induces alterations of epigenetic modulatory signatures in human cervical cancer cells.
    Anticancer Agents Med Chem. 2017 Sep 18. doi: 10.2174/1871520617666170918142114.
    PubMed     Text format     Abstract available


    Biochem Cell Biol

  4. LIU Y, Yang Y, Li L, Liu Y, et al
    LncRNA SNHG1 enhances cell proliferation, migration and invasion in cervical cancer.
    Biochem Cell Biol. 2017 Sep 20. doi: 10.1139/bcb-2017-0188.
    PubMed     Text format     Abstract available


    Cancer

  5. GUO M, Khanna A, Wang J, Dawlett MA, et al
    Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
    Cancer. 2017 May 12. doi: 10.1002/cncy.21877.
    PubMed     Text format     Abstract available

  6. GE Y, Christensen P, Luna E, Armylagos D, et al
    Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer.
    Cancer. 2017 Jun 2. doi: 10.1002/cncy.21875.
    PubMed     Text format     Abstract available


    Cancer Cell Int

  7. LIN J, Lu J, Wang C, Xue X, et al
    The prognostic values of the expression of Vimentin, TP53, and Podoplanin in patients with cervical cancer.
    Cancer Cell Int. 2017;17:80.
    PubMed     Text format     Abstract available


    Cancer Prev Res (Phila)

  8. DONG L, Hu SY, Zhang Q, Feng R, et al
    Risk Prediction of Cervical Cancer and Precancers by Type-specific Human Papillomavirus: Evidence from a Population-based Cohort Study in China.
    Cancer Prev Res (Phila). 2017 Sep 15. pii: canprevres.0088.2017.
    PubMed     Text format     Abstract available


    Cancer Sci

  9. YOSHIMATSU Y, Nakahara T, Tanaka K, Inagawa Y, et al
    Roles of the PDZ-binding motif of HPV 16 E6 protein in oncogenic transformation of human cervical keratinocytes.
    Cancer Sci. 2017;108:1303-1309.
    PubMed     Text format     Abstract available


    Curr Opin Oncol

  10. LLEWELYN M, Taylor A
    Re-irradiation of cervical and endometrial cancer.
    Curr Opin Oncol. 2017;29:343-350.
    PubMed     Text format     Abstract available


    Eur J Cancer Care (Engl)

  11. RODER D, Davy M, Selva-Nayagam S, Gowda R, et al
    The value of local registry data for describing cervical cancer management and outcomes over three decades in Australia.
    Eur J Cancer Care (Engl). 2017 Sep 20. doi: 10.1111/ecc.12760.
    PubMed     Text format     Abstract available


    Eur J Med Res

  12. ACHARYA PANDEY R, Karmacharya E
    Cervical cancer screening behavior and associated factors among women of Ugrachandi Nala, Kavre, Nepal.
    Eur J Med Res. 2017;22:32.
    PubMed     Text format     Abstract available


    Eur J Nucl Med Mol Imaging

  13. SCHERNBERG A, Reuze S, Orlhac F, Buvat I, et al
    A score combining baseline neutrophilia and primary tumor SUVpeak measured from FDG PET is associated with outcome in locally advanced cervical cancer.
    Eur J Nucl Med Mol Imaging. 2017 Sep 15. doi: 10.1007/s00259-017-3824.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  14. RASPAGLIESI F, Bogani G, Spinillo A, Ditto A, et al
    Introducing nerve-sparing approach during minimally invasive radical hysterectomy for locally-advanced cervical cancer: A multi-institutional experience.
    Eur J Surg Oncol. 2017 Sep 7. pii: S0748-7983(17)30654.
    PubMed     Text format     Abstract available


    Exp Ther Med

  15. MENG X, Zhao Y, Wang J, Gao Z, et al
    Regulatory roles of miRNA-758 and matrix extracellular phosphoglycoprotein in cervical cancer.
    Exp Ther Med. 2017;14:2789-2794.
    PubMed     Text format     Abstract available


    Fam Community Health

  16. MORALES-CAMPOS DY, Parra-Medina D
    Predictors of Human Papillomavirus Vaccine Initiation and Completion Among Latino Mothers of 11- to 17-Year-Old Daughters Living Along the Texas-Mexico Border.
    Fam Community Health. 2017;40:139-149.
    PubMed     Text format     Abstract available


    Front Public Health

  17. FILADE TE, Dareng EO, Olawande T, Fagbohun TA, et al
    Attitude to Human Papillomavirus Deoxyribonucleic Acid-Based Cervical Cancer Screening in Antenatal Care in Nigeria: A Qualitative Study.
    Front Public Health. 2017;5:226.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  18. RAUH LA, Pannone AF, Cantrell LA
    Hormone replacement therapy after treatment for cervical cancer: Are we adhering to standard of care?
    Gynecol Oncol. 2017 Sep 16. pii: S0090-8258(17)31333.
    PubMed     Text format     Abstract available

  19. HUO D, Anderson D, Palmer JR, Herbst AL, et al
    Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up.
    Gynecol Oncol. 2017;146:566-571.
    PubMed     Text format     Abstract available

  20. AZAIS H, Ghesquiere L, Petitnicolas C, Borghesi Y, et al
    Pretherapeutic staging of locally advanced cervical cancer: Inframesenteric paraaortic lymphadenectomy accuracy to detect paraaortic metastases in comparison with infrarenal paraaortic lymphadenectomy.
    Gynecol Oncol. 2017 Sep 14. pii: S0090-8258(17)31334.
    PubMed     Text format     Abstract available

  21. CHAN JK, Deng W, Higgins RV, Tewari KS, et al
    A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study.
    Gynecol Oncol. 2017 Jul 17. pii: S0090-8258(17)30889.
    PubMed     Text format     Abstract available

  22. MOSS HA, Havrilesky LJ, Chino J
    Insurance coverage among women diagnosed with a gynecologic malignancy before and after implementation of the Affordable Care Act.
    Gynecol Oncol. 2017 Jun 19. pii: S0090-8258(17)30953.
    PubMed     Text format     Abstract available

  23. LOPEZ LABROUSSE MI, Frumovitz M, Guadalupe Patrono M, Ramirez PT, et al
    Sentinel lymph node mapping in minimally invasive surgery: Role of imaging with color-segmented fluorescence (CSF).
    Gynecol Oncol. 2017;146:676-677.
    PubMed     Text format     Abstract available


    Int J Cancer

  24. CHASIMPHA SJD, Parkin DM, Masamba L, Dzamalala CP, et al
    Three-year cancer incidence in Blantyre, Malawi (2008-2010).
    Int J Cancer. 2017;141:694-700.
    PubMed     Text format     Abstract available

  25. DE MARTEL C, Plummer M, Vignat J, Franceschi S, et al
    Worldwide burden of cancer attributable to HPV by site, country and HPV type.
    Int J Cancer. 2017 Apr 1. doi: 10.1002/ijc.30716.
    PubMed     Text format     Abstract available

  26. CLARKE MA, Luhn P, Gage JC, Bodelon C, et al
    Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer.
    Int J Cancer. 2017;141:701-710.
    PubMed     Text format     Abstract available


    Int J Gynaecol Obstet

  27. PATEL H, Pcolkina K, Strazdina K, Viberga I, et al
    Awareness of HPV infection and attitudes toward HPV vaccination among Latvian adolescents.
    Int J Gynaecol Obstet. 2017 Feb 7. doi: 10.1002/ijgo.12117.
    PubMed     Text format     Abstract available

  28. HAN Y, Li N, Zhang R, Li X, et al
    Role of positive peritoneal cytology in FIGO stage IB to IIB cervical adenocarcinoma.
    Int J Gynaecol Obstet. 2017;137:150-156.
    PubMed     Text format     Abstract available


    Int J Nanomedicine

  29. YUAN YG, Gurunathan S
    Combination of graphene oxide-silver nanoparticle nanocomposites and cisplatin enhances apoptosis and autophagy in human cervical cancer cells.
    Int J Nanomedicine. 2017;12:6537-6558.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  30. FRIESE K, Kost B, Vattai A, Marme F, et al
    The G protein-coupled estrogen receptor (GPER/GPR30) may serve as a prognostic marker in early-stage cervical cancer.
    J Cancer Res Clin Oncol. 2017 Sep 18. doi: 10.1007/s00432-017-2510.
    PubMed     Text format     Abstract available


    J Health Commun

  31. MAERTENS JA, Jimenez-Zambrano AM, Albright K, Dempsey AF, et al
    Using Community Engagement to Develop a Web-Based Intervention for Latinos about the HPV Vaccine.
    J Health Commun. 2017;22:285-293.
    PubMed     Text format     Abstract available


    J Immigr Minor Health

  32. UYSAL TORAMAN A, Yildirim N
    Knowledge About Cervical Cancer Risk Factors and Practices of Pap Testing Among Turkish Immigrant Women in the United States.
    J Immigr Minor Health. 2017 Sep 19. doi: 10.1007/s10903-017-0653.
    PubMed     Text format     Abstract available


    J Oncol

  33. SHARKAS G, Arqoub K, Khader Y, Nimri O, et al
    Trends in the Incidence of Cervical Cancer in Jordan, 2000-2013.
    J Oncol. 2017;2017:6827384.
    PubMed     Text format     Abstract available


    J Pathol

  34. KRANJEC C, Holleywood C, Libert D, Griffin H, et al
    Modulation of basal cell fate during productive and transforming HPV-16 infection is mediated by progressive E6-driven depletion of Notch.
    J Pathol. 2017;242:448-462.
    PubMed     Text format     Abstract available


    J Robot Surg

  35. NEVIS IF, Vali B, Higgins C, Dhalla I, et al
    Robot-assisted hysterectomy for endometrial and cervical cancers: a systematic review.
    J Robot Surg. 2017;11:1-16.
    PubMed     Text format     Abstract available


    J Surg Oncol

  36. KIM HS, Kim M, Luo Y, Lee M, et al
    Favorable factors for preserving bladder function after nerve-sparing radical hysterectomy: A protocol-based validation study.
    J Surg Oncol. 2017;116:492-499.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep

  37. FOWLER CI, Saraiya M, Moskosky SB, Miller JW, et al
    Trends in Cervical Cancer Screening in Title X-Funded Health Centers - United States, 2005-2015.
    MMWR Morb Mortal Wkly Rep. 2017;66:981-985.
    PubMed     Text format     Abstract available


    Mutat Res

  38. CARDOSO MFS, Castelletti CHM, Lima-Filho JL, Martins DBG, et al
    Putative biomarkers for cervical cancer: SNVs, methylation and expression profiles.
    Mutat Res. 2017;773:161-173.
    PubMed     Text format     Abstract available


    Oncoimmunology

  39. KOMDEUR FL, Prins TM, van de Wall S, Plat A, et al
    CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer.
    Oncoimmunology. 2017;6:e1338230.
    PubMed     Text format     Abstract available


    Oncol Lett

  40. SHI C, Zhang Z
    MicroRNA-320 suppresses cervical cancer cell viability, migration and invasion via directly targeting FOXM1.
    Oncol Lett. 2017;14:3809-3816.
    PubMed     Text format     Abstract available

  41. WANG X, Jiang Y, Yuan M, Chen C, et al
    Overexpression of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related protein in cervical cancer and correlation with squamous cell carcinoma antigen.
    Oncol Lett. 2017;14:2813-2821.
    PubMed     Text format     Abstract available

  42. WEI ZT, Yu XW, He JX, Liu Y, et al
    Characteristics of primary side population cervical cancer cells.
    Oncol Lett. 2017;14:3536-3544.
    PubMed     Text format     Abstract available


    Phys Med Biol

  43. ZHEN X, Chen J, Zhong Z, Hrycushko BA, et al
    Deep convolutional neural network with transfer learning for rectum toxicity prediction in cervical cancer radiotherapy: a feasibility study.
    Phys Med Biol. 2017 Sep 15. doi: 10.1088/1361-6560.
    PubMed     Text format     Abstract available


    PLoS One

  44. BERNAUDO S, Khazai S, Honarparvar E, Kopteva A, et al
    Epidermal growth factor promotes cyclin G2 degradation via calpain-mediated proteolysis in gynaecological cancer cells.
    PLoS One. 2017;12:e0179906.
    PubMed     Text format     Abstract available


    Updates Surg

  45. VALENTI G, Vitale SG, Tropea A, Biondi A, et al
    Tumor markers of uterine cervical cancer: a new scenario to guide surgical practice?
    Updates Surg. 2017 Sep 16. doi: 10.1007/s13304-017-0491.
    PubMed     Text format     Abstract available


    World J Surg Oncol

  46. TANG J, Yang Z, Wang Z, Li Z, et al
    Foxp3 is correlated with VEGF-C expression and lymphangiogenesis in cervical cancer.
    World J Surg Oncol. 2017;15:173.
    PubMed     Text format     Abstract available


    Zhonghua Liu Xing Bing Xue Za Zhi

  47. SONG ZC, Ding L, Ren ZY, Sun XS, et al
    [Effects of Src on cervical cancer cells proliferation and apoptosis through ERK signal transduction pathway].
    Zhonghua Liu Xing Bing Xue Za Zhi. 2017;38:1246-1251.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: